Rinal Möxämmätef

Recent publications · Crossref

5 total works indexed

1. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1

   · 2021 · cited 350x

2. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial

   · 2022 · cited 53x

3. Dalbavancin for Treatment of <i>Staphylococcus aureus</i> Bacteremia

   · 2025 · cited 29x

4. The Essential Role Played by B Cells in Supporting Protective Immunity Against Trichuris muris Infection Is by Controlling the Th1/Th2 Balance in the Mesenteric Lymph Nodes and Depends on Host Genetic Background

   · 2019 · cited 21x

5. The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections

   · 2022 · cited 17x

via Crossref · CC0